Adrenocortical carcinoma: Impact of surgical treatment

Ann Endocrinol (Paris). 2019 Nov;80(5-6):308-313. doi: 10.1016/j.ando.2019.09.001. Epub 2019 Oct 18.

Abstract

Compared to benign adrenal lesions, secreting or otherwise, malignant adrenocortical carcinoma is rare. Overall prognosis is poor, with <50% 5-year survival. Various prognostic factors have been identified, some tumor-related and others directly linked to surgical treatment. Surgery is the only possible curative treatment, and is decided upon in a multidisciplinary medical-surgical team meeting. Surgical approach (laparotomy vs. laparoscopy) remains a matter of debate. In the light of a recent literature search, the present review reassesses the prognostic criteria of surgical resection, the quality of which determines overall and recurrence-free survival.

Keywords: Adrenalectomy; Adrenocortical carcinoma; Cortico-surrénalome; Laparoscopie; Laparoscopy; Laparotomie; Laparotomy; Prognosis; Pronostic; Surrénalectomie.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adrenal Cortex Neoplasms / pathology
  • Adrenal Cortex Neoplasms / surgery*
  • Adrenocortical Carcinoma / pathology
  • Adrenocortical Carcinoma / surgery*
  • Humans
  • Laparoscopy
  • Laparotomy
  • Lymph Node Excision
  • Lymphatic Metastasis / pathology
  • Margins of Excision
  • Neoplasm Recurrence, Local / therapy
  • Survival Rate
  • Treatment Outcome*